Yes Gilver I agree we have something special - but I also beleive it's so special that most investors without an IT background (the Majority) don't realize how special it is.

This board is one of the biggest contirbutors to information on POET availlable given the comanies tight lip approach. So I think we have to be careful when posting milestones of these competitors to explain how they differ (as you mentioned are inferior to POET).

I've been doing alot of reading alot over the past 4 months but still can't get my head wrapped around this tech. Often some news of competitors triggers concern for me until I have to be the dummy and ask what it all means. I'm not asking you guys to spoon feed me - but just be mindful of this when posting tech DD from other companies. As we know we are hoping to attract new investors but alot of them obviously are not getting the major progress we have made and are awaiting revenue - I largely believe this is because the tech is too complicated to understand so they're on the sidelines for now.

I know when righting for new research approval and patient consent it has to be at a grade 8 level to ensure informed consent - I see no reason why it shouldn't be the same here making sure all investors know what they are getting into.

Now lets make some money!

-DC